Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen–Specific Challenge

BACKGROUND: The live attenuated vaccine Zostavax was developed to prevent varicella zoster virus (VZV) reactivation that causes herpes zoster (shingles) in older humans. However, the impact of vaccination on the cutaneous response to VZV is not known. METHODS: We investigated the response to intrade...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Infect Dis
Glavni autori: Patel, Neil P, Vukmanovic-Stejic, Milica, Suarez- Farinas, Mayte, Chambers, Emma S, Sandhu, Daisy, Fuentes-Duculan, Judilyn, Mabbott, Neil A, Rustin, Malcolm H A, Krueger, James, Akbar, Arne N
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Supplement Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151076/
https://ncbi.nlm.nih.gov/pubmed/30247603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy420
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items